首页> 外国专利> INDUCEMENT OF PROTECTIVE ACTION AGAINST VIRUS INFECTION BY SYNERGISM BETWEEN PEPTIDES COR- RESPONDING TO VIRUS ENVELOPE GLYCOPROTEIN AND NEUTRAL EPITOPE OF ITS GLYCOPROTEIN

INDUCEMENT OF PROTECTIVE ACTION AGAINST VIRUS INFECTION BY SYNERGISM BETWEEN PEPTIDES COR- RESPONDING TO VIRUS ENVELOPE GLYCOPROTEIN AND NEUTRAL EPITOPE OF ITS GLYCOPROTEIN

机译:对应于病毒包膜糖蛋白及其中性表位的肽之间协同作用引起的对病毒感染的保护作用

摘要

PURPOSE: To impart persistent immunity against virus to a host by administering a viral envelope glycoprotein and a peptide derived from an amino acid sequence of the envelope glycoprotein and containing neutralized epitope to the host, and enhancing the induction of a neutralizing antibody. CONSTITUTION: At least one viral envelope glycoprotein, preferably the whole molecule obtained before scission to be expected (e.g. gp 160 is preferable than gp 120 in a case of HIV-1) and a peptide derived from an amino acid sequence of the envelope glycoprotein and containing at least one neutralized epitope are administered to a host. Onset preventive vaccination is preferably performed by the injection of the envelope glycoprotein, and protective immunity is preferably enhanced by the injection of immunogenic peptide corresponding to the neutralized epitope.
机译:目的:通过向宿主施用病毒包膜糖蛋白和衍生自该包膜糖蛋白氨基酸序列并含有中和表位的肽来赋予宿主抗病毒的持久免疫力,并增强对中和抗体的诱导。组成:至少一种病毒包膜糖蛋白,优选是在分裂前预期获得的整个分子(例如,在HIV-1的情况下,gp 160比gp 120更优选)和衍生自包膜糖蛋白的氨基酸序列的肽将含有至少一个中和的表位的含有至少一种中和的表位施用于宿主。预防性预防接种优选通过包膜糖蛋白的注射来进行,并且保护性免疫优选通过注射对应于中和的表位的免疫原性肽来增强。

著录项

  • 公开/公告号JPH03271233A

    专利类型

  • 公开/公告日1991-12-03

    原文格式PDF

  • 申请/专利权人 INST PASTEUR;

    申请/专利号JP19900341189

  • 发明设计人 MARUKU JIRAARU;

    申请日1990-11-30

  • 分类号A61K38/00;A61K39/00;A61K39/39;A61K39/395;A61P31/12;A61P37/04;C07K14/00;C07K14/15;C07K14/155;C07K14/16;C07K14/705;C07K16/00;C12P21/08;

  • 国家 JP

  • 入库时间 2022-08-22 05:38:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号